Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03686345
Title Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia (AML FLT3)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Niguarda Hospital
Indications

core binding factor acute myeloid leukemia

Therapies

Midostaurin

Age Groups: adult | senior
Covered Countries


No variant requirements are available.